Companies

NEOGEN CORP (NEOG) SEC filings

CIK 0000711377 · In Vitro & In Vivo Diagnostic Substances (SIC 2835) · Nasdaq · incorporated in MI · fiscal year ends 05/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2026FY2025
Revenue (USD)870.4 M822.4 M
Net income (USD)-7.9 M-22.9 M
Diluted EPS (USD/shares)-0.04-0.12

Latest filings

FiledFormDescriptionPeriod
2026-10-20S-8S-8
2026-10-20S-8S-8
2026-10-094PRIMARY DOCUMENT2026-10-09
2026-10-0710-Q10-Q2026-08-31
2026-10-078-K8-K items 5.07,9.012026-10-01
2026-10-068-K8-K items 2.02,9.012026-10-06
2026-10-024PRIMARY DOCUMENT2026-10-01
2026-10-024PRIMARY DOCUMENT2026-10-01
2026-10-024PRIMARY DOCUMENT2026-10-01
2026-10-024PRIMARY DOCUMENT2026-10-01
2026-10-024PRIMARY DOCUMENT2026-10-01
2026-10-024PRIMARY DOCUMENT2026-10-01
2026-10-024PRIMARY DOCUMENT2026-10-01
2026-10-024PRIMARY DOCUMENT2026-10-01
2026-09-28DEFA14ADEFA14A
2026-08-21ARSARS2026-05-31
2026-08-21DEFA14ADEFA14A
2026-08-21DEF 14ADEF 14A2026-08-21
2026-08-204PRIMARY DOCUMENT2026-08-19
2026-08-204PRIMARY DOCUMENT2026-08-19
2026-08-144PRIMARY DOCUMENT2026-08-14
2026-08-144PRIMARY DOCUMENT2026-08-14
2026-08-144PRIMARY DOCUMENT2026-08-14
2026-08-144PRIMARY DOCUMENT2026-08-14
2026-08-144PRIMARY DOCUMENT2026-08-14

Forms on file (last 1,000): 4 598, 8-K 144, SC 13G/A 46, 10-Q 40, 3 19, 425 14, DEF 14A 13, 10-K 13. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=NEOG (0.002 USD), /gw/filings/filings?ticker=NEOG&form=8-K, /gw/filings/facts?ticker=NEOG&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange